INNV Stock Overview
InnovAge Holding Corp. manages and provides a range of medical and ancillary services for seniors in need of care and support to live independently in their homes and communities.
InnovAge Holding Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||US$6.04|
|52 Week High||US$9.21|
|52 Week Low||US$3.39|
|1 Month Change||55.67%|
|3 Month Change||56.48%|
|1 Year Change||-10.91%|
|3 Year Change||n/a|
|5 Year Change||n/a|
|Change since IPO||-75.04%|
Recent News & Updates
InnovAge GAAP EPS of -$0.09 misses by $0.06, revenue of $172.86M misses by $1.11M
InnovAge press release (NASDAQ:INNV): Q4 GAAP EPS of -$0.09 misses by $0.06. Revenue of $172.86M (+0.7% Y/Y) misses by $1.11M. Adjusted EBITDA margin of 4.9%, a decrease of 8.5 percentage points compared to 13.4% in 2021 Census of approximately 6,650 compared to 6,850 in 2021 Ended the fiscal year with $184.4 million in cash and cash equivalents and $86.4 million in debt on the balance sheet, representing debt under the Company’s senior secured term loan, convertible term loan and capital leases Due to the inherent uncertainty and open timeline around sanction release, we will not provide forward looking guidance for fiscal year 2023.
|INNV||US Healthcare||US Market|
Return vs Industry: INNV underperformed the US Healthcare industry which returned 5.3% over the past year.
Return vs Market: INNV exceeded the US Market which returned -23.7% over the past year.
|INNV Average Weekly Movement||11.1%|
|Healthcare Industry Average Movement||8.3%|
|Market Average Movement||6.9%|
|10% most volatile stocks in US Market||15.7%|
|10% least volatile stocks in US Market||2.8%|
Stable Share Price: INNV is more volatile than 75% of US stocks over the past 3 months, typically moving +/- 11% a week.
Volatility Over Time: INNV's weekly volatility (11%) has been stable over the past year, but is still higher than 75% of US stocks.
About the Company
InnovAge Holding Corp. manages and provides a range of medical and ancillary services for seniors in need of care and support to live independently in their homes and communities. It manages its business through Program of All-Inclusive Care for the Elderly (PACE) approach. The company offers in-home care services consisting of skilled, unskilled, and personal care; in-center services, such as primary care, physical therapy, occupational therapy, speech therapy, dental services, mental health and psychiatric services, meals, and activities; transportation to the PACE center and third-party medical appointments; and care management.
InnovAge Holding Fundamentals Summary
|INNV fundamental statistics|
Is INNV overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|INNV income statement (TTM)|
|Cost of Revenue||US$180.22m|
Last Reported Earnings
Jun 30, 2022
Next Earnings Date
|Earnings per share (EPS)||-0.048|
|Net Profit Margin||-0.93%|
How did INNV perform over the long term?See historical performance and comparison
Is INNV undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score 3/6
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Below Fair Value
Significantly Below Fair Value
Key Valuation Metric
Which metric is best to use when looking at relative valuation for INNV?
Other financial metrics that can be useful for relative valuation.
|What is INNV's n/a Ratio?|
Price to Sales Ratio vs Peers
How does INNV's PS Ratio compare to its peers?
|INNV PS Ratio vs Peers|
|Company||PS||Estimated Growth||Market Cap|
NRC National Research
INNV InnovAge Holding
Price-To-Sales vs Peers: INNV is good value based on its Price-To-Sales Ratio (1.2x) compared to the peer average (2.6x).
Price to Earnings Ratio vs Industry
How does INNV's PE Ratio compare vs other companies in the US Healthcare Industry?
Price-To-Sales vs Industry: INNV is good value based on its Price-To-Sales Ratio (1.2x) compared to the US Healthcare industry average (1.3x)
Price to Sales Ratio vs Fair Ratio
What is INNV's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
|Current PS Ratio||1.2x|
|Fair PS Ratio||5.4x|
Price-To-Sales vs Fair Ratio: INNV is good value based on its Price-To-Sales Ratio (1.2x) compared to the estimated Fair Price-To-Sales Ratio (5.4x).
Share Price vs Fair Value
What is the Fair Price of INNV when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: Insufficient data to calculate INNV's fair value for valuation analysis.
Significantly Below Fair Value: Insufficient data to calculate INNV's fair value for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Target price is lower than the current share price.
Discover undervalued companies
How is InnovAge Holding forecast to perform in the next 1 to 3 years based on estimates from 5 analysts?
Future Growth Score4/6
Future Growth Score 4/6
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings
Revenue vs Market
High Growth Revenue
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: INNV is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (1.9%).
Earnings vs Market: INNV is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: INNV is expected to become profitable in the next 3 years.
Revenue vs Market: INNV's revenue (13.2% per year) is forecast to grow faster than the US market (7.6% per year).
High Growth Revenue: INNV's revenue (13.2% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: INNV's Return on Equity is forecast to be low in 3 years time (8.6%).
Discover growth companies
How has InnovAge Holding performed over the past 5 years?
Past Performance Score0/6
Past Performance Score 0/6
Growing Profit Margin
Earnings vs Industry
Last years earnings growth
Earnings and Revenue History
Quality Earnings: INNV is currently unprofitable.
Growing Profit Margin: INNV is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: Insufficient data to determine if INNV's year-on-year earnings growth rate was positive over the past 5 years.
Accelerating Growth: Unable to compare INNV's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: INNV is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (3.2%).
Return on Equity
High ROE: INNV has a negative Return on Equity (-2.25%), as it is currently unprofitable.
Discover strong past performing companies
How is InnovAge Holding's financial position?
Financial Health Score4/6
Financial Health Score 4/6
Short Term Liabilities
Long Term Liabilities
Stable Cash Runway
Forecast Cash Runway
Financial Position Analysis
Short Term Liabilities: INNV's short term assets ($241.0M) exceed its short term liabilities ($105.3M).
Long Term Liabilities: INNV's short term assets ($241.0M) exceed its long term liabilities ($96.5M).
Debt to Equity History and Analysis
Debt Level: INNV has more cash than its total debt.
Reducing Debt: Insufficient data to determine if INNV's debt to equity ratio has reduced over the past 5 years.
Cash Runway Analysis
For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: INNV has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if INNV has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.
Discover healthy companies
What is InnovAge Holding current dividend yield, its reliability and sustainability?
Dividend Score 0/6
Cash Flow Coverage
Dividend Yield vs Market
|InnovAge Holding Dividend Yield vs Market|
|Company (InnovAge Holding)||n/a|
|Market Bottom 25% (US)||1.7%|
|Market Top 25% (US)||4.7%|
|Industry Average (Healthcare)||1.4%|
|Analyst forecast in 3 Years (InnovAge Holding)||0%|
Notable Dividend: Unable to evaluate INNV's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate INNV's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if INNV's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if INNV's dividend payments have been increasing.
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as INNV has not reported any payouts.
Discover strong dividend paying companies
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Patrick Blair (51 yo)
Mr. Patrick Blair serves as President of InnovAge Holding Corp. since December 1, 2021 and as its CEO since January 01, 2022. He had been the Chief Marketing Officer and Senior Vice President of Commercial...
Experienced Management: INNV's management team is not considered experienced ( 1.3 years average tenure), which suggests a new team.
Experienced Board: INNV's board of directors are not considered experienced ( 1.5 years average tenure), which suggests a new board.
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: INNV insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
|15 Sep 22||BuyUS$509,800||Thomas Scully||Individual||100,000||US$5.10|
|Owner Type||Number of Shares||Ownership Percentage|
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
|Ownership||Name||Shares||Current Value||Change %||Portfolio %|
InnovAge Holding Corp.'s employee growth, exchange listings and data sources
- Name: InnovAge Holding Corp.
- Ticker: INNV
- Exchange: NasdaqGS
- Founded: 2007
- Industry: Health Care Services
- Sector: Healthcare
- Implied Market Cap: US$818.817m
- Shares outstanding: 135.57m
- Website: https://www.innovage.com
Number of Employees
- InnovAge Holding Corp.
- 8950 East Lowry Boulevard
- United States
|Ticker||Exchange||Primary Security||Security Type||Country||Currency||Listed on|
|INNV||NasdaqGS (Nasdaq Global Select)||Yes||Common Stock||US||USD||Mar 2021|
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2022/09/27 00:00|
|End of Day Share Price||2022/09/27 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.